| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/20/2008 | EP1404653B1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 08/20/2008 | EP1375489B1 Medicinal composition containing 1,3-thiazine derivative |
| 08/20/2008 | EP1363639B1 PYRROLO 2,3-d PYRIMIDINE AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 08/20/2008 | EP1345955B1 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
| 08/20/2008 | EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
| 08/20/2008 | EP1249233B1 Npyy5 antagonists |
| 08/20/2008 | EP1087992B1 Antithrombotic compounds |
| 08/20/2008 | EP0883404B1 Combination therapy for osteoporosis |
| 08/20/2008 | EP0703897B1 Lipoxin compounds with prolonged half-life |
| 08/20/2008 | CN101248074A Xanthine oxidase inhibitor |
| 08/20/2008 | CN101247818A Use of MAS G-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for prevention and treatment of diseases |
| 08/20/2008 | CN101245097A Inhibitors of serine proteases, particular hcv NS3-NS4 protease |
| 08/20/2008 | CN101245058A Inhibitors of aspartyl protease |
| 08/20/2008 | CN101244229A Powder medicine for treating hernia |
| 08/20/2008 | CN101244225A Externally used medical ointment for regain consciousness, refrigerating and relieving summer-heat, and preparation thereof |
| 08/20/2008 | CN101244160A New anti-stress and tidepressant purpose of banana tegument extract |
| 08/20/2008 | CN101244099A Method for preparing valid target in gavel fruit vine fruit and application of the same |
| 08/20/2008 | CN101244080A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 08/20/2008 | CN101244070A Polyene phosphatidylcholine high-capacity injection |
| 08/20/2008 | CN101244062A Sustained release pharmaceutical compositions and methods of treatment using the same |
| 08/20/2008 | CN101244047A Application of octacosanol in preparing medicament for preventing and controlling altitude erythrocytosis |
| 08/20/2008 | CN101243864A Application of flatstem milkvetch seed as fatigue resistant health food |
| 08/20/2008 | CN100412196C Protection against environmental toxicity through manipulation of processing of messenger RNA precursors |
| 08/20/2008 | CN100412091C Analogs of parathyroid hormone |
| 08/20/2008 | CN100412090C Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/20/2008 | CN100412063C Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same |
| 08/20/2008 | CN100411686C Visual function improving agents |
| 08/20/2008 | CN100411684C Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
| 08/20/2008 | CN100411683C Medicinal compositions containing ghrelin |
| 08/20/2008 | CN100411671C Chinese medicinal composition for relieving sports fatigue and improving performance and method for preparing same |
| 08/20/2008 | CN100411658C Edible health protection product possessing auxiliary improving function and physical strength fatigue delaying function |
| 08/20/2008 | CN100411641C Use of dripping pill in preparing medicine for treating anti-aspirin |
| 08/20/2008 | CN100411639C Use of compound red-rooted salvia drop pills in preparation of albumin leakage prohibiting drug |
| 08/20/2008 | CN100411622C Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative |
| 08/20/2008 | CN100411620C Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/20/2008 | CN100411619C Composition for suppressing blood sugar ascending |
| 08/20/2008 | CN100411618C Use of compounds that are effective as selective opiate receptor modulators |
| 08/19/2008 | US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping |
| 08/19/2008 | US7414077 Therapeutic intervention to mimic the effect of caloric restriction |
| 08/19/2008 | US7414073 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 08/19/2008 | US7414072 Aryl 5-thio-β-d-glucopyranoside derivatives and therapeutic agents for diabetes containing the same |
| 08/19/2008 | US7414071 Such as 5-(3-(2S-(3R-hydroxy-4-(3-trifluoromethyl-phenyl)-butyl)-5-oxo-pyrrolidin-1 -yl)-propyl)-thiophene-2-carboxylic acid; prostaglandin E2 agonists subtypes (EP4); for treatment of (ocular) hypertension, liver failure, and glaucoma |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7414046 Gyrase inhibitors and uses thereof |
| 08/19/2008 | US7414026 Inhibitors of NF-kappaB activation |
| 08/19/2008 | US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody |
| 08/19/2008 | US7414023 polypeptides/peptidomimetics; solid phase synthesis; for use in diagnositc assays |
| 08/19/2008 | US7413850 Uses of carbamoyl phosphate synthetase for the diagnois of inflammatory diseases and sepsis |
| 08/19/2008 | US7413756 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 08/19/2008 | US7413747 Transdermal therapeutic system for treating Parkinsonism |
| 08/19/2008 | CA2488422C Stable solid medicinal ramosetron composition for oral administration |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2390886C Use of fumaric acid derivatives for treating mitochondrial diseases |
| 08/19/2008 | CA2205134C A method for treating vascular headaches |
| 08/19/2008 | CA2120731C Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 08/14/2008 | WO2008098216A2 Compositions and methods to prevent cancer with cupredoxins |
| 08/14/2008 | WO2008098077A2 Substituted alkine derivatives as anti-cancer agents |
| 08/14/2008 | WO2008097897A2 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1) |
| 08/14/2008 | WO2008096894A1 Cellulose derivative and method for production thereof |
| 08/14/2008 | WO2008096870A1 Aza-bridged-ring compound |
| 08/14/2008 | WO2008096865A1 Therapeutic agent for disease induced by dysfunction or degeneration of organ |
| 08/14/2008 | WO2008096841A1 Dimerized cyclo derivative |
| 08/14/2008 | WO2008096829A1 Tricyclic compounds |
| 08/14/2008 | WO2008096820A1 Biphenyl derivative |
| 08/14/2008 | WO2008096791A1 Acylguanidine derivative |
| 08/14/2008 | WO2008096781A1 Betacellulin mutein |
| 08/14/2008 | WO2008096777A1 Therapeutic agent for irritable bowel syndrome |
| 08/14/2008 | WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives |
| 08/14/2008 | WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof |
| 08/14/2008 | WO2008096746A1 Spiro compound and use thereof |
| 08/14/2008 | WO2008096722A1 Agent for preventing bleeding from cerebral cortical vein |
| 08/14/2008 | WO2008095735A1 Use of sirt7 for treating age-related diseases |
| 08/14/2008 | WO2008044054A3 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 08/14/2008 | WO2007059209A9 Extract of dioscorea sp. and the medical uses thereof |
| 08/14/2008 | WO2007055950A3 Polycation-polyanion complexes, compositions and methods of use thereof |
| 08/14/2008 | US20080195032 Photosensitizer formulations and their use |
| 08/14/2008 | US20080194838 Carvedilol |
| 08/14/2008 | US20080194826 4-aminopiperidines react with 2-furancarboxylic acid or 2-furoyl chloride; opiod antagonist |
| 08/14/2008 | US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia |
| 08/14/2008 | US20080194687 particle obtained by granulating 1-aminomethyl-cyclohexane-acetic acid with polyethylene glycol; antiepileptic agents |
| 08/14/2008 | US20080194658 N-(4-{[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]amino}phenyl)acetamide; treating high serum levels of total cholesterol, low density lipoprotein and triglycerides |
| 08/14/2008 | US20080194630 LTA4H modulators and uses thereof |
| 08/14/2008 | US20080194627 Aryl substituted pyridines and the use thereof |
| 08/14/2008 | US20080194603 Prevent transplant rejection; autoimmune diseases |
| 08/14/2008 | US20080194597 Platelet adp receptor inhibitors |
| 08/14/2008 | US20080194591 Anhydrous Crystalline Forms Of N-[1-(2-Ethoxyethyl)-5-(N-Ethyl-N-Methylamino)-7-(4-Methylpyridin-2-Yl-Amino)-1H-Pyrazolo[4,3-D]Pyrimidine-3-Carbonyl]Methanesulfonamide |
| 08/14/2008 | US20080194515 Extracting DNA from a blood or buccal cell sample, PCR, resolution, and identification of differences in sequences between the extracted DNA and PCR primers; drug screening |
| 08/14/2008 | US20080194514 Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences |
| 08/14/2008 | US20080194508 Cell Counting |
| 08/14/2008 | US20080194495 1-amino-2,3-dihydroxy-5-hydroxymethyl-cyclopent-4-yl 4-O-(6-deoxy- alpha -D-glucopyranosyl)- alpha -D-glucopyranoside; alpha-amylase inhibitor; antidiabetic agents, hypoglycemic agents; side effect reduction |
| 08/14/2008 | US20080194480 Polypeptide for reducing the growth rate of cancer cells; polypeptide of given sequence that is down-regulated in cancer |
| 08/14/2008 | US20080194478 Wound healing agent and composition |
| 08/14/2008 | US20080194476 Medicament Comprising A Peptide Extract Of Avocado, Which Is Intended For The Treatment And Prevention Of Illnesses That Are Linked To An Immune System Deficiency |
| 08/14/2008 | US20080194473 Intraventricular administration of hepatocyte growth factor (HGF) |
| 08/14/2008 | US20080194469 Biodrug such as eptifibatide with blend of a hydrolyzable hydrophobic polymer containing diphenolic tyrosine monomer such as poly(desaminotyrosyltyrosine hexyl ester adipate (Poly(DTH adipate)), and another less hydrophobic hydrolyzable polymer that degrades to form acidic groups, releasing the biodrug |
| 08/14/2008 | US20080194460 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders |
| 08/14/2008 | US20080193964 Compositions and methods for regulation of calcium-dependent signaling in brain |